Alzheimer's Disease Neuroimaging Initiative in Europe

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The North American Alzheimer's Disease Neuroimaging Initiative (ADNI) was originally conceived as a study to develop markers of disease progression, but has also become a strong technological platform for the multi-centric collection of clinical data and imaging and biological markers. Because the ADNI platform was first imported in Europe, thanks to the pilot European ADNI, several ADNI-related initiatives have flourished, funded by the European Commission's 7th Framework Programme, national governments, and the Alzheimer's Association aimed at: (i) collecting fresh data ADNI style (FP7 AddNeuroMed, Innovative Medicine Initiative Pharma-Cog/European ADNI, Swedish ADNI, and Italian ADNI); (ii) developing standard operational procedures for the collection of markers (International Harmonization of CSF Abeta42 and tau, and European Alzheimer's Disease Consortium-ADNI Harmonization of Hippocampal Volumetry); and (iii) developing infrastructures for the treatment of ADNI data (FP7 neuGRID and outGRID, and the French Centre pour l'Acquisition et le Traitement de l'Image). Although this fragmented scenario is not surprising given the structure of scientific funding in Europe, opportunities are being developed for high order networking and harmonization at the continental level (Joint Programming for Neurodegenerative Diseases).

Original languageEnglish
Pages (from-to)280-285
Number of pages6
JournalAlzheimer's and Dementia
Volume6
Issue number3
DOIs
Publication statusPublished - May 2010

Fingerprint

Neuroimaging
Alzheimer Disease
Federal Government
Neurodegenerative Diseases
Disease Progression
Biomarkers
Medicine

Keywords

  • ADNI
  • Alzheimer's disease
  • International cooperation
  • Joint Programming

ASJC Scopus subject areas

  • Health Policy
  • Epidemiology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health
  • Cellular and Molecular Neuroscience
  • Developmental Neuroscience
  • Clinical Neurology
  • Medicine(all)

Cite this

Alzheimer's Disease Neuroimaging Initiative in Europe. / Frisoni, Giovanni B.

In: Alzheimer's and Dementia, Vol. 6, No. 3, 05.2010, p. 280-285.

Research output: Contribution to journalArticle

@article{7c5306a5470945a2b1a3f1511a33cf2a,
title = "Alzheimer's Disease Neuroimaging Initiative in Europe",
abstract = "The North American Alzheimer's Disease Neuroimaging Initiative (ADNI) was originally conceived as a study to develop markers of disease progression, but has also become a strong technological platform for the multi-centric collection of clinical data and imaging and biological markers. Because the ADNI platform was first imported in Europe, thanks to the pilot European ADNI, several ADNI-related initiatives have flourished, funded by the European Commission's 7th Framework Programme, national governments, and the Alzheimer's Association aimed at: (i) collecting fresh data ADNI style (FP7 AddNeuroMed, Innovative Medicine Initiative Pharma-Cog/European ADNI, Swedish ADNI, and Italian ADNI); (ii) developing standard operational procedures for the collection of markers (International Harmonization of CSF Abeta42 and tau, and European Alzheimer's Disease Consortium-ADNI Harmonization of Hippocampal Volumetry); and (iii) developing infrastructures for the treatment of ADNI data (FP7 neuGRID and outGRID, and the French Centre pour l'Acquisition et le Traitement de l'Image). Although this fragmented scenario is not surprising given the structure of scientific funding in Europe, opportunities are being developed for high order networking and harmonization at the continental level (Joint Programming for Neurodegenerative Diseases).",
keywords = "ADNI, Alzheimer's disease, International cooperation, Joint Programming",
author = "Frisoni, {Giovanni B.}",
year = "2010",
month = "5",
doi = "10.1016/j.jalz.2010.03.005",
language = "English",
volume = "6",
pages = "280--285",
journal = "Alzheimer's and Dementia",
issn = "1552-5260",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Alzheimer's Disease Neuroimaging Initiative in Europe

AU - Frisoni, Giovanni B.

PY - 2010/5

Y1 - 2010/5

N2 - The North American Alzheimer's Disease Neuroimaging Initiative (ADNI) was originally conceived as a study to develop markers of disease progression, but has also become a strong technological platform for the multi-centric collection of clinical data and imaging and biological markers. Because the ADNI platform was first imported in Europe, thanks to the pilot European ADNI, several ADNI-related initiatives have flourished, funded by the European Commission's 7th Framework Programme, national governments, and the Alzheimer's Association aimed at: (i) collecting fresh data ADNI style (FP7 AddNeuroMed, Innovative Medicine Initiative Pharma-Cog/European ADNI, Swedish ADNI, and Italian ADNI); (ii) developing standard operational procedures for the collection of markers (International Harmonization of CSF Abeta42 and tau, and European Alzheimer's Disease Consortium-ADNI Harmonization of Hippocampal Volumetry); and (iii) developing infrastructures for the treatment of ADNI data (FP7 neuGRID and outGRID, and the French Centre pour l'Acquisition et le Traitement de l'Image). Although this fragmented scenario is not surprising given the structure of scientific funding in Europe, opportunities are being developed for high order networking and harmonization at the continental level (Joint Programming for Neurodegenerative Diseases).

AB - The North American Alzheimer's Disease Neuroimaging Initiative (ADNI) was originally conceived as a study to develop markers of disease progression, but has also become a strong technological platform for the multi-centric collection of clinical data and imaging and biological markers. Because the ADNI platform was first imported in Europe, thanks to the pilot European ADNI, several ADNI-related initiatives have flourished, funded by the European Commission's 7th Framework Programme, national governments, and the Alzheimer's Association aimed at: (i) collecting fresh data ADNI style (FP7 AddNeuroMed, Innovative Medicine Initiative Pharma-Cog/European ADNI, Swedish ADNI, and Italian ADNI); (ii) developing standard operational procedures for the collection of markers (International Harmonization of CSF Abeta42 and tau, and European Alzheimer's Disease Consortium-ADNI Harmonization of Hippocampal Volumetry); and (iii) developing infrastructures for the treatment of ADNI data (FP7 neuGRID and outGRID, and the French Centre pour l'Acquisition et le Traitement de l'Image). Although this fragmented scenario is not surprising given the structure of scientific funding in Europe, opportunities are being developed for high order networking and harmonization at the continental level (Joint Programming for Neurodegenerative Diseases).

KW - ADNI

KW - Alzheimer's disease

KW - International cooperation

KW - Joint Programming

UR - http://www.scopus.com/inward/record.url?scp=77954033765&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954033765&partnerID=8YFLogxK

U2 - 10.1016/j.jalz.2010.03.005

DO - 10.1016/j.jalz.2010.03.005

M3 - Article

VL - 6

SP - 280

EP - 285

JO - Alzheimer's and Dementia

JF - Alzheimer's and Dementia

SN - 1552-5260

IS - 3

ER -